MDxHealth (MDXH) Research & Development (2021 - 2026)
MDxHealth (MDXH) posted Research & Development of -$2.1 million for Q1 2026, up 34.88% sequentially from -$3.3 million in Q4 2025, and up 14.61% YoY from -$1.9 million in Q1 2025.
MDxHealth (MDXH) Research & Development (2021 - 2026) Analysis & Trends
MDxHealth has reported Research & Development for 6 years, with the latest figure at -$2.1 million in Q1 2026.
- Quarterly Research & Development rose 14.61% year-over-year to -$2.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$12.5 million (down 14.74% YoY) and the FY2025 annual result came in at $10.4 million, down 1.91% from the prior year.
- Research & Development climbed to -$2.1 million in Q1 2026 per MDXH's latest filing, from -$3.3 million in the prior quarter.
- Over five years, Research & Development peaked at -$8045.0 in Q2 2025 and troughed at -$3.6 billion in Q2 2022.
- A 5-year average of -$212.9 million and a median of -$2.2 million in 2024 frame the typical range for Research & Development.
- The sharpest annual moves came in 2023 and 2025: Research & Development surged 99.95% in 2023, then tumbled 162.25% in 2025.
- Over 5 years, Research & Development stood at -$799000.0 in 2022, then slumped by 128.91% to -$1.8 million in 2023, then plunged by 52.43% to -$2.8 million in 2024, then decreased by 17.54% to -$3.3 million in 2025, then surged by 34.88% to -$2.1 million in 2026.
- According to Business Quant data, Research & Development over the past three periods registered -$2.1 million, -$3.3 million, and -$7.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.77 Bn | 209.71 Bn | 8.34 Bn | 364.00 Mn |
| 2 | Danaher | 139.78 Bn | 135.43 Bn | 3.61 Bn | 412.00 Mn |
| 3 | Idexx Laboratories | 46.04 Bn | 45.85 Bn | 779.09 Mn | 171.28 Mn |
| 4 | Agilent Technologies | 39.68 Bn | 37.88 Bn | 990.00 Mn | 126.00 Mn |
| 5 | Iqvia Holdings | 39.34 Bn | 37.26 Bn | 1.44 Bn | - |
| 6 | Natera | 38.75 Bn | 37.65 Bn | 696.04 Mn | 210.70 Mn |
| 7 | Illumina | 29.90 Bn | 28.73 Bn | 770.00 Mn | 252.00 Mn |
| 8 | Mettler Toledo International | 28.58 Bn | 28.53 Bn | 650.22 Mn | 52.99 Mn |
| 9 | Quest Diagnostics | 26.18 Bn | 25.55 Bn | 1.03 Bn | - |
| 10 | MDxHealth | 21.82 Mn | -21.33 Mn | 16.61 Mn | -2.13 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.13 Mn |
| Dec 31, 2025 | -3.28 Mn |
| Sep 30, 2025 | -7.07 Mn |
| Jun 30, 2025 | -8,045.00 |
| Mar 31, 2025 | -2.50 Mn |
| Dec 31, 2024 | -2.79 Mn |
| Sep 30, 2024 | -2.70 Mn |
| Jun 30, 2024 | -2.90 Mn |
| Mar 31, 2024 | -2.16 Mn |
| Dec 31, 2023 | -1.83 Mn |
| Sep 30, 2023 | -1.56 Mn |
| Jun 30, 2023 | -1.67 Mn |
| Mar 31, 2023 | -1.32 Mn |
| Dec 31, 2022 | -799,000.00 |
| Sep 30, 2022 | -2.17 Mn |
| Jun 30, 2022 | -3.58 Bn |
| Mar 31, 2022 | -1.78 Mn |
| Dec 31, 2021 | -1.26 Mn |
| Sep 30, 2021 | -1.50 Mn |